entertainment -WSS

entertainment

author：explore 2025-10-02 22:58:05 - browse：6

The ability of cancer cells to move and spread depends on actin-rich core structures such as the podosomes (yellow) shown here in melanoma cells. Cell nuclei (blue), actin (red), and an actin regulator (green) are also shown. — Metastatic melanoma cells Julio C. Valencia,/NCI Center for Cancer Research

Nearly four decades after its first conception, the first TIL therapy, an immunotherapy that harvests cancer-fighting immune cells from the patient’s own body, received accelerated approval from the Food and Drug Administration for advanced melanoma. The therapy, called Amtagvi or lifileucel from Iovance, is the first cell therapy approved for a solid tumor.

“It’s so exciting and gratifying,” said Allison Betof Warner, a cell therapy researcher and physician at Stanford University who has worked on Amtagvi. “This is a game-changing moment for our field. We’ve seen huge success of cellular therapy for hematologic malignancies, and we’ve yet to capitalize on that for solid tumors. This is hopefully the first of many to come.”

In a Phase 2 clinical trial, titled C-144-01, 153 patients who had already been on a median of three prior lines of therapy received lifileucel, and 31% of them responded to therapy. “These are in very late line patients. They’ve exhausted every standard care option,” Betof Warner said. “The most promising part of this therapy for me is that 42% of patients who responded were still responding for 18 months or longer. It’s truly incredible.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： JPM: CVS says Medicare Advantage patients are impacting profits

leisure time

WSS

3 medical device trends to watch in 2024

Feng Zhang, Grail founder join forces on new gene editing startup

WATCH: Why do bright lights make us see spots?

The FDA must approve intranasal treatments for anaphylaxis

Long Covid needs a new name — and a new frame

Long Covid needs a new name — and a new frame

Wikipedia

entertainment

knowledge

The cancer drug shortage isn’t new — and neither are the solutions

How to make the FDA’s new prescription one

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

New weight loss drugs vying to be the next Wegovy or Mounjaro

Anesthesiologist group: stop taking Ozempic before surgery

White House touts steps to stem shortages of cancer treatments

United colonoscopy coverage change 'may cost lives,' doctors say

IRA could hurt research into orphan drugs for rare diseases

Peter Hotez and the public health issue of online harassment

The biotech scorecard for Q1: 17 stock

hotspot

FDA panel endorses Alnylam’s heart drug — after picking it apart

Chronically ill young patients struggle to find fertility info

Walmart eyes Medicare Advantage provider ChenMed

JPM: CVS says Medicare Advantage patients are impacting profits

New weight loss drugs work. But how can they best be used?

J&J to buy cancer drug developer Ambrx Biopharma

leisure time

Wikipedia

knowledge

Wikipedia